Other Links
We are committed to driving significant growth through ambitious new product launches in each market, supported by our dedicated launch excellence function.
Our international offices in UAE, Saudi Arabia, Vietnam, Kenya and Greece enable us to maintain a strong global presence.
We embrace a range of strategies to drive our business growth, including expanding our product offerings, territorial expansion and leveraging inorganic methods such as whitespace opportunities through mature brand or portfolio acquisitions in our target markets, as well as joint ventures with prominent local players.
We are always open to exploring new opportunities and partnerships to further our mission. For business proposals, please reach out to us at bdm@remedica.com.cy. Let’s collaborate to create a brighter future together
In our home country and commercial forte, we hold an undisputed leading position in our operating areas. Key highlights of our commercial presence include:
We command over 22% of the market share in our operating areas.
We cover over 100% of local market pharmacies.
A team of 25+ medical representatives supports a wide range of Rx and OTC products.
We are leaders in the CVS, CNS, and Oncology therapy areas
We are deeply committed to delivering a best-in-class experience to healthcare professionals through innovative approaches. One of our pioneering initiatives is conducting Real World Evidence studies for our CVS products. These studies provide valuable insights and data, enhancing the efficacy and safety of our treatments and ultimately improving patient outcomes. We are also heavily focused on launching new products, both from our own portfolio and inlicensed offerings.
At Remedica, we believe in the power of humanity and the importance of giving back. We actively contribute to making a difference by supplying a wide range of our high-quality pharmaceutical products to various NGOs. These partnerships enable us to ensure that essential medicines reach the communities and regions where they are most needed. We are proud to collaborate with esteemed organizations such as
among others. These partnerships support the organisations’ missions to improve health outcomes and enhance the quality of life for underserved population
Our Clinical Trial Supply model plays a crucial role in the pharmaceutical sector by ensuring a reliable, continuous supply of essential medicines required for clinical trials. By providing comparator medicines, auxiliary medicine products, and placebos, we support the advancement of medical research and the development of new therapies across various global markets.
Our portfolio consists of over 300 products, with a focus on high-demand therapeutic areas like Oncology, Cardiology and Metabolics. Our manufacturing facilities are located in Cyprus and operate under EU-GMP (Good Manufacturing Practice) standards, ensuring the highest quality and safety in product production. Regulatory compliance is a cornerstone of our operations, with approvals from multiple Stringent Regulatory Authorities (SRAs). This ensures that our products meet the high standards required for clinical use, allowing us to operate confidently in various international markets.
